GL1X · GenesisL1 explorer

MolNFT v1 · #148712 · protein

Crystal structure of human DDR2 kinase in complex with 2-[4,5- difluoro-2-oxo-1'-(1H-PYRAZOLO[3,4-B]PYRIDINE-5-carbonyl) SPIRO[INDOLE-3,4'-piperidine]-1-yl]-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE

6FER · Discoidin domain-containing receptor 2: “Crystal structure of human DDR2 kinase in complex with 2-[4,5…”. X-ray diffraction, 1 ligand (D6Q), 20 pockets (best druggability 0.79). MolNFT v1 #148712 on GenesisL1: 3D structure, binding…

PDB
6FER
Type
protein
Length
3,275 residues
Chains
12
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Discoidin domain-containing receptor 2
EC
2.7.10.1
UniProt
Q16832
Ligands
D6Q
Pockets
20 · best druggability 0.79

Structure

x-ray diffraction · 12 distinct chains · 41% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADiscoidin domain-containing receptor 2 (EC 2.7.10.1)protein27141% helix, 15% strandQ16832
BDiscoidin domain-containing receptor 2 (EC 2.7.10.1)protein27941% helix, 16% strandQ16832
CDiscoidin domain-containing receptor 2 (EC 2.7.10.1)protein27242% helix, 17% strandQ16832
DDiscoidin domain-containing receptor 2 (EC 2.7.10.1)protein28039% helix, 15% strandQ16832
EDiscoidin domain-containing receptor 2 (EC 2.7.10.1)protein27342% helix, 16% strandQ16832
FDiscoidin domain-containing receptor 2 (EC 2.7.10.1)protein27540% helix, 17% strandQ16832
GDiscoidin domain-containing receptor 2 (EC 2.7.10.1)protein27340% helix, 16% strandQ16832
HDiscoidin domain-containing receptor 2 (EC 2.7.10.1)protein27244% helix, 15% strandQ16832
IDiscoidin domain-containing receptor 2 (EC 2.7.10.1)protein26742% helix, 17% strandQ16832
JDiscoidin domain-containing receptor 2 (EC 2.7.10.1)protein27242% helix, 15% strandQ16832
KDiscoidin domain-containing receptor 2 (EC 2.7.10.1)protein26844% helix, 16% strandQ16832
LDiscoidin domain-containing receptor 2 (EC 2.7.10.1)protein27341% helix, 16% strandQ16832

Ligands and binding sites

  • D6Q · 2-[4,5-bis(fluoranyl)-2-oxidanylidene-1'-(1~{H}-pyrazolo[3,4-b]pyridin-5-ylcarbonyl)spiro[indole-3,4'-piperidine]-1-yl]-~{N}-[2,2,2-tris(fluoranyl) ethyl]ethanamide · ligand · 12 copies · chains A, B, C, D, E, F, G, H, I, J, K, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19540.790.8190D6Q
29200.760.7980D6Q
36220.760.8254D6Q
411600.760.7893D6Q
510720.760.7888D6Q

Interfaces

22 interfaces between chains.

  • B–L · 714 Ų buried · 3 hydrogen bonds · protein-protein
  • A–H · 704 Ų buried · 5 hydrogen bonds · protein-protein
  • H–K · 696 Ų buried · 3 hydrogen bonds · protein-protein
  • D–I · 666 Ų buried · 5 hydrogen bonds · protein-protein
  • A–K · 639 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 6FER · Crystal Structure of human DDR2 kinase in complex with… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.